Logo Logo
Hilfe
Hilfe
Switch Language to English

Zimny, Sebastian; Koob, Dennis; Li, Jingguo; Wimmer, Ralf; Schiergens, Tobias; Nagel, Jutta; Reiter, Florian Paul; Denk, Gerald und Hohenester, Simon (2022): Hydrophobic Bile Salts Induce Pro-Fibrogenic Proliferation of Hepatic Stellate Cells through PI3K p110 Alpha Signaling. In: Cells, Bd. 11, Nr. 15 [PDF, 2MB]

Abstract

Bile salts accumulating during cholestatic liver disease are believed to promote liver fibrosis. We have recently shown that chenodeoxycholate (CDC) induces expansion of hepatic stellate cells (HSCs) in vivo, thereby promoting liver fibrosis. Mechanisms underlying bile salt-induced fibrogenesis remain elusive. We aimed to characterize the effects of different bile salts on HSC biology and investigated underlying signaling pathways. Murine HSCs (mHSCs) were stimulated with hydrophilic and hydrophobic bile salts. Proliferation, cell mass, collagen deposition, and activation of signaling pathways were determined. Activation of the human HSC cell line LX 2 was assessed by quantification of alpha-smooth muscle actin (alpha SMA) expression. Phosphatidyl-inositol-3-kinase (PI3K)-dependent signaling was inhibited both pharmacologically and by siRNA. CDC, the most abundant bile salt accumulating in human cholestasis, but no other bile salt tested, induced Protein kinase B (PKB) phosphorylation and promoted HSC proliferation and subsequent collagen deposition. Pharmacological inhibition of the upstream target PI3K-inhibited activation of PKB and pro-fibrogenic proliferation of HSCs. The PI3K p110 alpha-specific inhibitor Alpelisib and siRNA-mediated knockdown of p110 alpha ameliorated pro-fibrogenic activation of mHSC and LX 2 cells, respectively. In summary, pro-fibrogenic signaling in mHSCs is selectively induced by CDC. PI3K p110 alpha may be a potential therapeutic target for the inhibition of bile salt-induced fibrogenesis in cholestasis.

Dokument bearbeiten Dokument bearbeiten